Your browser doesn't support javascript.
loading
Large-scale imatinib dose-concentration-effect study in CML patients under routine care conditions.
Gotta, Verena; Bouchet, Stephane; Widmer, Nicolas; Schuld, Peter; Decosterd, Laurent A; Buclin, Thierry; Mahon, Francois-Xavier; Csajka, Chantal; Molimard, Mathieu.
Afiliação
  • Gotta V; Division of Clinical Pharmacology, Service of Biomedicine, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland; School of Pharmaceutical Sciences, University of Geneva, University of Lausanne, Geneva, Switzerland.
  • Bouchet S; Department of Clinical Pharmacology and Toxicology, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France.
  • Widmer N; Division of Clinical Pharmacology, Service of Biomedicine, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland.
  • Schuld P; Novartis Oncology Region Europe, Milan, Italy.
  • Decosterd LA; Laboratory of Clinical Pharmacology, Innovation & Development Unit, Service of Biomedicine, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland.
  • Buclin T; Division of Clinical Pharmacology, Service of Biomedicine, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland.
  • Mahon FX; Laboratoire Hématopoïèse Leucémique et Cible Thérapeutique, Université Victor Ségalen Bordeaux 2, Bordeaux, France.
  • Csajka C; Division of Clinical Pharmacology, Service of Biomedicine, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland; School of Pharmaceutical Sciences, University of Geneva, University of Lausanne, Geneva, Switzerland. Electronic address: Chantal.Csajka@chuv.ch.
  • Molimard M; Novartis Oncology Region Europe, Milan, Italy.
Leuk Res ; 38(7): 764-72, 2014 Jul.
Article em En | MEDLINE | ID: mdl-24844604

Texto completo: 1 Coleções: 01-internacional Temas: Cuidados_paliativos / Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Piperazinas / Pirimidinas / Benzamidas / Leucemia Mielogênica Crônica BCR-ABL Positiva / Inibidores de Proteínas Quinases / Antineoplásicos Tipo de estudo: Observational_studies / Prognostic_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Leuk Res Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Suíça

Texto completo: 1 Coleções: 01-internacional Temas: Cuidados_paliativos / Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Piperazinas / Pirimidinas / Benzamidas / Leucemia Mielogênica Crônica BCR-ABL Positiva / Inibidores de Proteínas Quinases / Antineoplásicos Tipo de estudo: Observational_studies / Prognostic_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Leuk Res Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Suíça